ey0020.2-10 | Long-Acting Growth Hormone (LAGH) | ESPEYB20
X Luo
, S Zhao
, Y Yang
, G Dong
, L Chen
, P Li
, F Luo
, C Gong
, Z Xu
, X Xu
, H Gong
, H Du
, L Hou
, Y Zhong
, Q Shi
, X Chen
, X Chen
, L Xu
, R Cheng
, C Su
, Y Ma
, L Xu
, L Zhang
, H Lu
Brief summary: This randomized, multicenter, controlled, phase II study compared the effects of high-dose (HD) once-weekly PEGylated-recombinant human growth hormone (PEG-rhGH) to low-dose (LD) and to an untreated control group of children with idiopathic short stature (ISS) over a period of 52 weeks. PEG-rhGH was effective in increasing height gain in a dose dependent manner with both doses being well tolerated during the observation period.PEG-rhGH is ...